Next Article in Journal
Review of Guidelines on the Treatment of Metastatic Renal Cell Carcinoma
Previous Article in Journal
Role of Cytokine Therapy for Renal Cell Carcinoma in the Era of Targeted Agents
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Managing Toxicities and Optimal Dosing of Targeted Drugs in Advanced Kidney Cancer

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2009, 16(s1), 52-59; https://doi.org/10.3747/co.v16i0.402
Submission received: 11 February 2009 / Revised: 4 March 2009 / Accepted: 9 April 2009 / Published: 1 May 2009

Abstract

The toxicities of new, targeted drugs may diminish their effectiveness in advanced kidney cancer if those toxicities are not recognized and properly addressed early in patient treatment. Most of the drug-related toxicities in advanced kidney cancer are manageable with supportive care, obviating a need for long interruptions, dose reductions, or permanent discontinuation of the treatment.
Keywords: sunitinib; sorafenib; temsirolimus; toxicity; side effects; management sunitinib; sorafenib; temsirolimus; toxicity; side effects; management

Share and Cite

MDPI and ACS Style

Seruga, B.; Gan, H.K.; Knox, J.J. Managing Toxicities and Optimal Dosing of Targeted Drugs in Advanced Kidney Cancer. Curr. Oncol. 2009, 16, 52-59. https://doi.org/10.3747/co.v16i0.402

AMA Style

Seruga B, Gan HK, Knox JJ. Managing Toxicities and Optimal Dosing of Targeted Drugs in Advanced Kidney Cancer. Current Oncology. 2009; 16(s1):52-59. https://doi.org/10.3747/co.v16i0.402

Chicago/Turabian Style

Seruga, B., H. K. Gan, and J. J. Knox. 2009. "Managing Toxicities and Optimal Dosing of Targeted Drugs in Advanced Kidney Cancer" Current Oncology 16, no. s1: 52-59. https://doi.org/10.3747/co.v16i0.402

Article Metrics

Back to TopTop